|
1
|
Liechty KW, MacKenzie TC, Shaaban AF, Radu
A, Moseley AM, Deans R, Marshak DR and Flake AW: Human mesenchymal
stem cells engraft and demonstrate site-specific differentiation
after in utero transplantation in sheep. Nat Med. 6:1282–1286.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Orlic D, Kajstura J, Chimenti S, Limana F,
Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A and Anversa
P: Mobilized bone marrow cells repair the infarcted heart,
improving function and survival. Proc Natl Acad Sci USA.
98:10344–10349. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kudo M, Wang Y, Wani MA, Xu M, Ayub A and
Ashraf M: Implantation of bone marrow stem cells reduces the
infarction and fibrosis in ischemic mouse heart. J Mol Cell
Cardiol. 35:1113–1119. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Z, Gu TX and Zhang YH: Hepatocyte
growth factor combined with insulin like growth factor-1 improves
expression of GATA-4 in mesenchymal stem cells cocultured with
cardiomyocytes. Chin Med J (Engl). 121:336–340. 2008.PubMed/NCBI
|
|
5
|
Rangappa S, Entwistle JW, Wechsler AS and
Kresh JY: Cardiomyocyte-mediated contact programs human mesenchymal
stem cells to express cardiogenic phenotype. J Thorac Cardiovasc
Surg. 126:124–132. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Haylor J, Hickling H, El Eter E, Moir A,
Oldroyd S, Hardisty C and El Nahas AM: JB3, an IGF-I receptor
antagonist, inhibits early renal growth in diabetic and
uninephrectomized rats. J Am Soc Nephrol. 11:2027–2035.
2000.PubMed/NCBI
|
|
7
|
Hu C, Wu Y, Wan Y, Wang Q and Song J:
Introduction of hIGF-1 gene into bone marrow stromal cells and its
effects on the cell's biological behaviors. Cell Transplant.
17:1067–1081. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schnabel LV, Lynch ME, van der Meulen MC,
Yeager AE, Kornatowski MA and Nixon AJ: Mesenchymal stem cells and
insulin-like growth factor-I gene-enhanced mesenchymal stem cells
improve structural aspects of healing in equine flexor digitorum
superficialis tendons. J Orthop Res. 27:1392–1398. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blum G, Gazit A and Levitzki A: Substrate
competitive inhibitors of IGF-1 receptor kinase. Biochemistry.
39:15705–15712. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Urbich C, Aicher A, Heeschen C, Dernbach
E, Hofmann WK, Zeiher AM and Dimmeler S: Soluble factors released
by endothelial progenitor cells promote migration of endothelial
cells and cardiac resident progenitor cells. J Mol Cell Cardiol.
39:733–742. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu M, Uemura R, Dai Y, Wang Y, Pasha Z and
Ashraf M: In vitro and in vivo effects of bone marrow stem cells on
cardiac structure and function. J Mol Cell Cardiol. 42:441–448.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Su EJ, Cioffi CL, Stefansson S, Mittereder
N, Garay M, Hreniuk D and Liau G: Gene therapy vector-mediated
expression of insulin-like growth factors protects cardiomyocytes
from apoptosis and enhances neovascularization. Am J Physiol Heart
Circ Physiol. 284:H1429–H1440. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo J, Lin G, Bao C, Hu Z, Chu H and Hu M:
Insulin-like growth factor 1 improves the efficacy of mesenchymal
stem cells transplantation in a rat model of myocardial infarction.
J Biomed Sci. 15:89–97. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Panepucci RA, Siufi JL, Silva WA Jr,
Proto-Siquiera R, Neder L, Orellana M, Rocha V, Covas DT and Zago
MA: Comparison of gene expression of umbilical cord vein and bone
marrow-derived mesenchymal stem cells. Stem Cells. 22:1263–1278.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Scotlandi K, Manara MC, Nicoletti G,
Lollini PL, Lukas S, Benini S, Croci S, Perdichizzi S, Zambelli D,
Serra M, et al: Antitumor activity of the insulin-like growth
factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal
tumors. Cancer Res. 65:3868–3876. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shake JG, Gruber PJ, Baumgartner WA,
Senechal G, Meyers J, Redmond JM, Pittenger MF and Martin BJ:
Mesenchymal stem cell implantation in a swine myocardial infarct
model: Engraftment and functional effects. Ann Thorac Surg.
73:1919–1925; discussion 1926. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li G, Borger MA, Williams WG, Weisel RD,
Mickle DA, Wigle ED and Li RK: Regional overexpression of
insulin-like growth factor-I and transforming growth factor-beta1
in the myocardium of patients with hypertrophic obstructive
cardiomyopathy. J Thorac Cardiovasc Surg. 123:89–95. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Welch S, Plank D, Witt S, Glascock B,
Schaefer E, Chimenti S, Andreoli AM, Limana F, Leri A, Kajstura J,
et al: Cardiac-specific IGF-1 expression attenuates dilated
cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ
Res. 90:641–648. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bayes-Genis A, Conover CA and Schwartz RS:
The insulin-like growth factor axis: A review of atherosclerosis
and restenosis. Circ Res. 86:125–130. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Beamer WG, Donahue LR and Rosen CJ:
Insulin-like growth factor I and bone: From mouse to man. Growth
Horm IGF Res. 10:S103–S105. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Madry H, Zurakowski D and Trippel SB:
Overexpression of human insulin-like growth factor-I promotes new
tissue formation in an ex vivo model of articular chondrocyte
transplantation. Gene Ther. 8:1443–1449. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Yu X, Lin S, Li X, Zhang S and Song
YH: Insulin-like growth factor 1 enhances the migratory capacity of
mesenchymal stem cells. Biochem Biophys Res Commun. 356:780–784.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kofidis T, de Bruin JL, Yamane T, Balsam
LB, Lebl DR, Swijnenburg RJ, Tanaka M, Weissman IL and Robbins RC:
Insulin-like growth factor promotes engraftment, differentiation,
and functional improvement after transfer of embryonic stem cells
for myocardial restoration. Stem Cells. 22:1239–1245. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Larsson O, Girnita A and Girnita L: Role
of insulin-like growth factor 1 receptor signalling in cancer. Br J
Cancer. 92:2097–2101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pollak MN, Schernhammer ES and Hankinson
SE: Insulin-like growth factors and neoplasia. Nat Rev Cancer.
4:505–518. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
McMahon LA, Prendergast PJ and Campbell
VA: A comparison of the involvement of p38, ERK1/2 and PI3K in
growth factor-induced chondrogenic differentiation of mesenchymal
stem cells. Biochem Biophys Res Commun. 368:990–995. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peyssonnaux C and Eychène A: The
Raf/MEK/ERK pathway: New concepts of activation. Biol Cell.
93:53–62. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wong KK: Recent developments in
anti-cancer agents targeting the Ras/Raf/MEK/ERK pathway. Recent
Patents Anticancer Drug Discov. 4:28–35. 2009. View Article : Google Scholar
|
